Scholarly Index
Andreas du Bois
Kliniken Essen-Mitte; 34,462 total citations; 785 total publications; best world rank #6
Kliniken Essen-Mitte
34,462Total citations
785Total publications
87H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Intraperitoneal and Appendiceal Malignancies | Lifetime | 6 | DE 1 | 99.74 |
| Endometrial and Cervical Cancer Treatments | Lifetime | 26 | DE 1 | 99.71 |
| Ovarian cancer diagnosis and treatment | Lifetime | 33 | DE 2 | 99.72 |
| Cancer Treatment and Pharmacology | Lifetime | 393 | DE 18 | 98.86 |
| PARP inhibition in cancer therapy | Lifetime | 139 | DE 11 | 97.94 |
| Renal cell carcinoma treatment | Lifetime | 523 | DE 26 | 97.82 |
| Chemotherapy-induced organ toxicity mitigation | Lifetime | 67 | DE 5 | 96.59 |
| Endometriosis Research and Treatment | Lifetime | 565 | DE 24 | 97.15 |
| Lung Cancer Research Studies | Lifetime | 914 | DE 47 | 97.09 |
| BRCA gene mutations in cancer | Lifetime | 766 | DE 27 | 95.53 |
| Nausea and vomiting management | Lifetime | 385 | DE 23 | 95.24 |
| Chemotherapy-related skin toxicity | Lifetime | 355 | DE 16 | 89.54 |
| Ovarian cancer diagnosis and treatment | 2021-2025 | 253 | DE 13 | 96.15 |
| Endometrial and Cervical Cancer Treatments | 2021-2025 | 941 | DE 36 | 87.54 |
| Intraperitoneal and Appendiceal Malignancies | 2021-2025 | 359 | DE 13 | 85.04 |
| PARP inhibition in cancer therapy | 2021-2025 | 628 | DE 32 | 84.03 |